SU
Suven Pharma
SUVENPHAR.NS·NSEHyderabad INFounded 20201,200 employees
Mid CappharmaPublicCNS
Platform: CNS CDMO
Market Cap
$2B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SUVENPHAR.NS)
Loading SUVENPHAR.NS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| SUV-4226 | SUV-4226 | Phase 3 | 2 | AHR | Melanoma | ||
| SUV-9449 | SUV-9449 | Phase 3 | 2 | FcRn | ALLNMOSD |
SEC Filings & Financial Documents
SEC filings are not available for NSE-listed companies.
Suven Pharma trades on NSE (IN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (2)